Browse by category

Abdominal obesity and muscle loss increases the risk of death by 83% after age 50

A study by researchers at the Federal University of São Carlos (UFSCar) in Brazil, in partnership with University College London (UCL) in the United Kingdom, has concluded that the combination of abdominal fat and muscle loss increases the risk of death by 83%, compared to people without these conditions. This combination is so dangerous that it identifies an even greater problem: sarcopenic obesity. This condition is characterised by loss of muscle mass while gaining fat thr

FDA approves Veru’s trial with Enobosarm to treat muscle loss associated with weight loss drugs

The FDA has cleared Veru’s Investigational New Drug (IND) application for its Phase 2b clinical study to evaluate enobosarm, an oral...

Abdominal obesity and muscle loss increases the risk of death by 83% after age 50

9 hours ago

Triple agonist retatrutide delivers average 71.2 lbs weight loss

3 days ago

First patient treated in EASE clinical trial evaluating the EndoZip Automated Suturing System for ESG

4 days ago

Browse by category

Abdominal obesity and muscle loss increases the risk of death by 83% after age 50

FDA approves Veru’s trial with Enobosarm to treat muscle loss associated with weight loss drugs

Browse by tag

Abdominal obesity and muscle loss increases the risk of death by 83% after age 50

Triple agonist retatrutide delivers average 71.2 lbs weight loss

First patient treated in EASE clinical trial evaluating the EndoZip Automated Suturing System for ESG

Back to Top